User profiles for "author:M Green"

Martin A Green

- Verified email at unsw.edu.au - Cited by 121887

Michael Green

- Verified email at ucla.edu - Cited by 72001

Mark A Green

- Verified email at liverpool.ac.uk - Cited by 22594

The emergence of perovskite solar cells

MA Green, A Ho-Baillie, HJ Snaith - Nature photonics, 2014 - nature.com
The past two years have seen the unprecedentedly rapid emergence of a new class of solar
cell based on mixed organic–inorganic halide perovskites. Although the first efficient solid …

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?

MF Green, RS Kern, DL Braff, J Mintz - Schizophrenia bulletin, 2000 - academic.oup.com
There has been a surge of interest in the functional consequences of neurocognitive deficits
in schizophrenia. The published literature in this area has doubled in the last few years. In …

What are the functional consequences of neurocognitive deficits in schizophrenia?

MF Green - The American journal of psychiatry, 1996 - europepmc.org
Objective It has been well established that schizophrenic patients have neurocognitive
deficits, but it is not known how these deficits influence the daily lives of patients. The goal of …

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease …

M Ng, T Fleming, M Robinson, B Thomson, N Graetz… - The lancet, 2014 - thelancet.com
Background In 2010, overweight and obesity were estimated to cause 3· 4 million deaths, 3·
9% of years of life lost, and 3· 8% of disability-adjusted life-years (DALYs) worldwide. The …

[HTML][HTML] Remdesivir for the treatment of Covid-19

…, TH Burgess, T Bonnett, M Green… - … England Journal of …, 2020 - Mass Medical Soc
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

HA Burris 3rd, MJ Moore, J Andersen… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit
their daily activities because of tumor-related symptoms. To date, no treatment has had a …

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from …

C Allemani, T Matsuda, V Di Carlo, R Harewood… - The Lancet, 2018 - thelancet.com
Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou… - Nature, 2022 - nature.com
Schizophrenia has a heritability of 60–80%, much of which is attributable to common risk
alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with …

Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

DA Melton, PA Krieg, MR Rebagliati… - Nucleic acids …, 1984 - academic.oup.com
A simple and efficient method for synthesizing pure single stranded RNAs of virtually any
structure is described. This in vitro transcription system is based on the unusually specific …

The global burden of cancer 2013

…, K Soreide, L Knibbs, M Kereselidze, M Green… - JAMA …, 2015 - jamanetwork.com
Importance Cancer is among the leading causes of death worldwide. Current estimates of
cancer burden in individual countries and regions are necessary to inform local cancer …